Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA] - N0000193943

Name: Table of NDC products with mitogen-activated protein kinase kinase 1 inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193943
Pharmacologic Name	Mitogen-Activated Protein Kinase Kinase 1 Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Mitogen-Activated Protein Kinase Kinase 1 Inhibitors

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0310-0610	Koselugo	Non-Proprietary Name: Selumetinib	Capsule	Oral	Astrazeneca Pharmaceuticals Lp	ACTIVE
0310-0625	Koselugo	Non-Proprietary Name: Selumetinib	Capsule	Oral	Astrazeneca Pharmaceuticals Lp	ACTIVE
0310-0635	Koselugo	Non-Proprietary Name: Selumetinib	Granule	Oral	Astrazeneca Pharmaceuticals Lp	ACTIVE
0310-0640	Koselugo	Non-Proprietary Name: Selumetinib	Granule	Oral	Astrazeneca Pharmaceuticals Lp	ACTIVE